Continuing its efforts to encourage innovation in the medical device market while raising standards, China is considering revoking its requirement that medical devices be tested only in testing centers certified by the National Medical Products Administration (NMPA).
But it is uncertain whether the eased regulation will be implemented. Requirements to ensure the quality of third-party testing sites have not been issued, and there is no framework for certifying, supervising and managing such testing sites.